The present invention relates generally to medical devices and, in particular, aortic cannulas for use in ex vivo organ care systems. Specifically the invention relates to aortic cannulas used to return perfusate to the heart or delivering perfusate from the heart while the organ is sustained ex vivo at physiologic or near-physiologic conditions.
Current organ preservation techniques typically involve hypothermic storage of the organ in a chemical perfusate solution on ice. However, uses of conventional approaches results in injuries that increase as a function of the length of time an organ is maintained ex-vivo. These time restrictions limit the number of recipients who can be reached from a given donor site, thereby restricting the recipient pool for a harvested heart. Even within the few hour time limit, the heart may nevertheless be significantly damaged.
Effective preservation of an ex-vivo organ would also provide numerous other benefits. For instance, prolonged ex-vivo preservation would permit more careful monitoring and functional testing of the harvested organ. This would in turn allow earlier detection and potential repair of defects in the harvested organ, further reducing the likelihood of transplantation failure. The ability to perform simple repairs on the organ would also allow many organs with minor defects to be saved, whereas current transplantation techniques require them to be discarded. In addition, more effective matching between the organ and a particular recipient may be achieved, further reducing the likelihood of eventual organ rejection.
Improved ex-vivo organ care has been achieved through the use of an ex-vivo organ care system which maintains organs at physiologic or near-physiologic conditions. Not only does the system maintain the organ at physiologic temperatures, but in the case of the heart, the system maintains perfusate flow through the organ. In addition the system measures and monitors electric stimulation in the heart. The ex vivo organ care system where the heart sustained ex vivo at physiologic or near-physiologic conditions are described in application Ser. No. 11/822,495 entitled “Systems for monitoring and applying electrical currents in an organ perfusion system,” U.S. Pat. No. 8,304,181 entitled “Method for ex-vivo organ care and for using lactate as an indication of donor organ status,” and U.S. Pat. No. 8,409,846 entitled “Compositions, methods and devices for maintaining an organ,” which are incorporated herein by reference.
To maintain physiologic or near-physiologic perfusate flow through the heart, the organ must interface with the system via the aorta. This interface is achieved via an aortic cannula. Current aortic cannula designs lead to organ slippage, difficulties in maintaining a liquid tight seal, and damage to the aorta. Often these designs rely solely upon a cable tie in contact with the aorta to tighten the aorta to the aortic cannula. Depending on the size of the aorta and the size of the aortic cannula, there is a risk of laceration due to the cable ties exerting too much tension on aortic tissue, or the risk of leakage if they do not exert sufficient tension. Thus, there exists a need for an aortic cannula that is easy for health care workers to deploy, creates a tight seal with the aorta, reduces aortic slipping, and causes minimal damage to the aorta.
In view of the foregoing, improved devices for attaching the aorta to the system and methods of use in ex vivo organ care systems are needed.
In one embodiment the invention includes an aortic cannula for use with an ex vivo organ care system and methods of using the same. One aspect of the invention includes an aortic cannula comprising, a cannula body which further comprises, a fitting adapted to connect to an organ care system, an aorta interface to contact an aorta, and a pivot arm strap operably connected to a pivot mount, wherein the pivot mount allows the pivot arm strap to uniformly contact the aorta to hold the aorta on the aorta interface. In one embodiment, the aortic cannula further comprises a pivot arm connected to the pivot arm strap and to the pivot mount, such that when the pivot arm is moved toward the cannula body by rotation around the pivot mount the pivot arm strap moves away from the cannula body. In another embodiment of the aortic cannula the pivot arm and the pivot arm strap are parts of a single piece. In another embodiment, the aortic cannula comprises a spring which applies pressure to the pivot arm strap to hold the aorta on the aorta interface. In another embodiment of the aortic cannula a dowel pin communicates with the spring to allow the pivot arm to rotate around the dowel pin. In another embodiment of the aortic cannula the pivot arm further comprises a grip pad used to depress the top of the pivot arm. In another embodiment of the aortic cannula the grip pad is textured. In another embodiment of the aortic cannula the grip pad is removable. In another embodiment of the aortic cannula the pivot arm straps further comprise a loop and guide which retain a cable tie around the pivot arm strap. In another embodiment, the aortic cannula further comprises windows sized to normalize the compression exerted on the aorta by the cable tie such that the same amount of pressure will be exerted on the aorta regardless of the size of the pivot arm strap for a given cable tie tension. In another embodiment, the aortic cannula further comprises a connector used to reversibly secure the aortic cannula to an organ chamber. In another embodiment of the aortic cannula the connector is a threaded locking nut. In another embodiment of the aortic cannula the aorta interface is textured.
One aspect of the invention includes a method of using an aortic cannula to place a heart in fluid communication with an organ care system the method comprising, selecting an aortic cannula sized to fit the aorta of the heart the aortic cannula comprising, a cannula body further comprising, a fitting adapted to connect to an organ care system, an aorta interface to contact an aorta, and a pivot arm strap operably connected to a pivot mount, wherein the pivot mount allows the pivot arm strap to uniformly contact the aorta to hold the aorta on the aorta interface, depressing the pivot arm such that it rotates around the dowel pin and the pivot arm strap moves away from the cannula body, placing the cannula in the aorta, releasing the pivot arm, tightening a cable tie around the pivot arm strap to hold the aorta in place, and inserting the tapered fitting into an organ care system. In one embodiment, the method further comprises the step of suturing surgical felt pledgets on the aorta before placing the aorta on the aortic cannula.
The following figures depict illustrative embodiments of the invention.
Cannula Body
One of skill in the art would recognize that the while the shape of the cannula body 114 should be generally cylindrical, the opening need not be perfectly circular. The three sub-sections, tapered fitting 108, tapered midsection 130, and aorta interface 132, may be of different lengths relative to one another. In addition the different subsections may be made from one piece and they may have the same diameter. One of skill in the art would also recognize that the taper angle in the sub-sections, tapered fitting 108, tapered midsection 130, and aorta interface 132, may vary so long as the aorta interface reaches a diameter within the typical range of the diameter of an human aorta.
One end of the aortic cannula 100 forms tapered fitting 108. The tapered fitting is sized to couple to a female connector on an organ chamber (not shown) to create a seal. A threaded locking nut 102, pictured in
One of skill in the art would understand that the aortic cannula 100 can be connected to an organ care system or any other tube, device, or path of flow. In addition, one of skill in the art would appreciate that the locking nut 102 may be omitted in embodiments where the male-female connection between the aortic cannula 100 and the organ care system (not shown) is tight enough to prevent leakage. One of skill in the art would also recognize that the locking nut 102 could be replaced with other types of connectors generally used in the art to create a flow path between two tubes.
The tapered midsection 130 extends from the bottom edge of the tapered fitting 108 to the top edge of the aorta interface 132. The tapered midsection 130 reaches a final diameter the size of the aorta interface 132. The tapered midsection 130 helps to ensure smooth fluid flow from the aorta interface 132 to the tapered fitting 108. The tapered midsection 130 also helps minimize air trap and hemolysis and improve hemodynamics due to the smooth transition in flow path. The tapered midsection 130 has a pivot mount 122 and a spring pocket 106. The pivot mount 122 and the spring pocket 106 may be integrated with the tapered midsection 130. In one embodiment, the tapered midsection 130 has two pivot mounts 122 and two spring pockets 106, shown in
One of skill in the art would also recognize that the torsional spring could be replaced with other types of spring loading mechanisms or omitted completely. The torsional spring could also be replaced by a molded leaf spring on the pivot arm or on the grip pad. With the use of a molded leaf spring the dowel pin would be omitted and cylindrical bosses on the cannula body 114 or a similar structure could be used to perform the same function.
The aorta interface 132 is located adjacent the tapered midsection 130. The aorta interface 132 may be of a constant diameter and sized to fit within the aorta. The diameter of the aorta interface 132 can be between 0.5 and 2 inches. In some embodiments the diameter of the aorta interface 132 can be between 0.75 and 1.125 inches. Preferably, in some embodiments the diameter of the aorta interface is 0.75 inches, 0.875 inches, 1 inch, or 1.125 inches. The aorta interface 132 may be smooth or textured.
Pivot Arm
A pivot arm 140 is coupled to the pivot mount 122.
Pivot Arm Strap
The pivot arm strap 124 is coupled to the pivot arm 140. The pivot arm strap is best seen in
In one embodiment, the aorta is secured to the cannula body. The grip pad 116 is depressed by the user causing the pivot arm 140 to move around the sliding pivot window 118 and to compress torsional spring. The pivot arm 140 rotates around the dowel pin 120 in the sliding pivot window 118 and the pivot arm straps 124 move away from the cannula body 114, which makes room to place the cannula in the aorta in a preferred manner than if the pivot point were fixed. When the grip pad 116 is released the torsional spring (not shown) exerts pressure on the pivot arm strap 124 and temporarily holds the aorta in place. The straps closes on the aorta and the sliding pivot window 118 allows the pivot point to change in order to compensate for variations in tissue thickness and maintain alignment and concentricity of pivot arm 140 to cannula body 114 through the full range of rotation. This allows the strap 124 to seat uniformly on the aorta. Then, the cable tie is threaded through the loop 136 and between the guide 142. The cable tie is tightened to a predetermined tension. One of skill in the art would understand that the cable tie could be replaced with other mechanisms for securing the pivot arm straps 124. In some embodiments the cable tie can come preassembled in the loops 136.
Pledgets
In some embodiments, the user may suture surgical felt pledgets on the aorta. The pledgets serve as an additional measure to retain the aorta on the cannula body 114 because the pledgets provide a barrier that does not slide between the pivot arm strap 124 and the cannula body 114. Four sets of two (one inside, one outside) pledgets are equally spaced around the aorta and sutured. One of skill in the art will recognize that more or fewer pledgets may be used. In one embodiment, the aorta is positioned onto the cannula body 114 so that the pledgets are not directly above a space between the pivot arms 140 to prevent the pledgets from sliding through the space between the two sides of the pivot arm straps 124. It will be recognized by one of skill in the art that the pledgets may be placed anywhere on the aorta and end up in any orientation with respect to the pivot arm straps. The pledgets may be standard, surgical felt pledgets. Alternatively, they may be injected molded, rigid, elastomeric pledgets made of a high Durometer material, such as silicone, or a similar material. One of skill in the art would understand that the pledgets could be replaced with other materials that attach to the tissue, and that provide an anchor to prevent the device from sliding between the strap and the cannula body or damaging the tissue. Examples of these materials include, but are not limited to, a continuous ring of material that attaches to the tissue or a staple.
Tip Holder
The aortic cannula 100 may be used to connect a heart to an organ chamber (not shown). The aortic cannula 100 holds the aorta open and in place and allows perfusate to be perfused through the heart so the heart can be maintained in near physiologic conditions. In one embodiment, to deploy the aortic cannula, the user first selects an aortic cannula 100 that is sized to fit the heart. In one embodiment the aortic cannula 100 may be selected by measuring the aorta. The user depresses the thumb pads 116 on the spring-loaded pivot arms. When the user depresses the grip pads 116, the pivot arms 140 rotate around the dowel pin 120 within the sliding pivot window 118 and the pivot arm straps 124 move away from the cannula body 114 making room to place the cannula in the aorta. The user can place the cannula in the aorta. Then the user releases the thumb pads allowing the pivot arms 140 to close on the aorta. The pivot arms 140 may be operated at the same time or individually. The pressure created by the torsional springs temporarily holds the aorta in place. The user may adjust the aorta position, if necessary, such that aorta is fully engaged on the cannula body 114. Next the user places a cable tie through the loops 136 and guides 142 in the pivot arm straps 124. The user then tightens the cable tie to hold the aorta in place. In some embodiments the cable tie may be tightened using a tool which tightens the cable tie to a predetermined force. The user inserts the tapered fitting 108 into the organ chamber (not shown). Then the user tightens the locking nut 102. One of skill in the art will recognize that in some embodiments the aortic cannula 100 could first be seated in the organ chamber and then the aorta could be secured to the aortic cannula 100.
This application is a continuation of U.S. application Ser. No. 15/258,194 filed Sep. 7, 2016 which claims the benefit of U.S. Provisional Application Ser. No. 62/215,825, titled “Aortic Cannula for Ex Vivo Organ Care System,” filed Sep. 9, 2015. The specifications of each of the foregoing are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3253595 | Keller, Jr. et al. | May 1966 | A |
3388803 | Scott | Jun 1968 | A |
3406531 | Koski et al. | Oct 1968 | A |
3468136 | Koski et al. | Sep 1969 | A |
3537956 | Falcone | Nov 1970 | A |
3545221 | Koski et al. | Dec 1970 | A |
3545605 | Robins | Dec 1970 | A |
3587567 | Schiff | Jun 1971 | A |
3607646 | de Roissart | Sep 1971 | A |
3632473 | Belzer et al. | Jan 1972 | A |
3639084 | Goldhaber | Feb 1972 | A |
3654085 | Fritz et al. | Apr 1972 | A |
3660241 | Michielsen | May 1972 | A |
3738914 | Thorne et al. | Jun 1973 | A |
3772153 | De Roissart | Nov 1973 | A |
3777507 | Burton et al. | Dec 1973 | A |
3843455 | Bier et al. | Oct 1974 | A |
3851646 | Sarns | Dec 1974 | A |
3881990 | Burton et al. | May 1975 | A |
3995444 | Clark et al. | Dec 1976 | A |
4186565 | Toledo-Pereyra | Feb 1980 | A |
4231354 | Kurtz et al. | Nov 1980 | A |
4415556 | Bretschneider | Nov 1983 | A |
4598697 | Numazawa et al. | Jul 1986 | A |
4605644 | Foker | Aug 1986 | A |
4666425 | Fleming | May 1987 | A |
4719201 | Foker | Jan 1988 | A |
4723939 | Anaise | Feb 1988 | A |
4745759 | Bauer et al. | May 1988 | A |
4759371 | Franetzki | Jul 1988 | A |
4801299 | Brendel et al. | Jan 1989 | A |
4847470 | Bakke | Jul 1989 | A |
4920044 | Bretan, Jr. | Apr 1990 | A |
5051352 | Martindale et al. | Sep 1991 | A |
5066578 | Wikman-Coffelt | Nov 1991 | A |
5141847 | Sugimachi et al. | Aug 1992 | A |
5145771 | Lemasters et al. | Sep 1992 | A |
5157930 | McGhee et al. | Oct 1992 | A |
5200398 | Strasberg et al. | Apr 1993 | A |
5217860 | Fahy et al. | Jun 1993 | A |
5285657 | Bacchi et al. | Feb 1994 | A |
5306711 | Andrews | Apr 1994 | A |
5326706 | Yland et al. | Jul 1994 | A |
5338662 | Sadri | Aug 1994 | A |
5356593 | Heiberger et al. | Oct 1994 | A |
5356771 | O'Dell | Oct 1994 | A |
5358931 | Rubinsky et al. | Oct 1994 | A |
5362622 | O'Dell et al. | Nov 1994 | A |
5370989 | Stern et al. | Dec 1994 | A |
5381510 | Ford et al. | Jan 1995 | A |
5385821 | O'Dell et al. | Jan 1995 | A |
5395314 | Klatz et al. | Mar 1995 | A |
5405742 | Taylor | Apr 1995 | A |
5407669 | Lindstrom et al. | Apr 1995 | A |
5407793 | Del Nido et al. | Apr 1995 | A |
5472876 | Fahy | Dec 1995 | A |
5473791 | Holcomb et al. | Dec 1995 | A |
5494822 | Sadri | Feb 1996 | A |
5498427 | Menasche | Mar 1996 | A |
5505709 | Funderburk et al. | Apr 1996 | A |
5514536 | Taylor | May 1996 | A |
5552267 | Stern et al. | Sep 1996 | A |
5554123 | Herskowitz | Sep 1996 | A |
5554497 | Raymond | Sep 1996 | A |
5571801 | Segall et al. | Nov 1996 | A |
5584804 | Klatz et al. | Dec 1996 | A |
5586438 | Fahy | Dec 1996 | A |
5588816 | Abbott et al. | Dec 1996 | A |
5599173 | Chen et al. | Feb 1997 | A |
5599659 | Brasile et al. | Feb 1997 | A |
5613944 | Segall et al. | Mar 1997 | A |
5643712 | Brasile | Jul 1997 | A |
5654266 | Chen et al. | Aug 1997 | A |
5656420 | Chien | Aug 1997 | A |
5679565 | Mullen et al. | Oct 1997 | A |
5693462 | Raymond | Dec 1997 | A |
5698536 | Segall et al. | Dec 1997 | A |
5699793 | Brasile | Dec 1997 | A |
5702881 | Brasile et al. | Dec 1997 | A |
5716378 | Minten | Feb 1998 | A |
5723281 | Segall et al. | Mar 1998 | A |
5733894 | Segall et al. | Mar 1998 | A |
5747071 | Segall et al. | May 1998 | A |
5752929 | Klatz et al. | May 1998 | A |
5770149 | Raible | Jun 1998 | A |
5776063 | Dittrich et al. | Jul 1998 | A |
5786136 | Mayer | Jul 1998 | A |
5787544 | Meade | Aug 1998 | A |
5807737 | Schill et al. | Sep 1998 | A |
5823799 | Tor et al. | Oct 1998 | A |
5843024 | Brasile | Dec 1998 | A |
5856081 | Fahy | Jan 1999 | A |
5882328 | Levy et al. | Mar 1999 | A |
5965433 | Gardetto et al. | Oct 1999 | A |
5998240 | Hamilton et al. | Dec 1999 | A |
6024698 | Brasile | Feb 2000 | A |
6034109 | Ramasamy et al. | Mar 2000 | A |
6042550 | Haryadi et al. | Mar 2000 | A |
6046046 | Hassanein | Apr 2000 | A |
6050987 | Rosenbaum | Apr 2000 | A |
6100082 | Hassanein | Aug 2000 | A |
6110139 | Loubser | Aug 2000 | A |
6110504 | Segall et al. | Aug 2000 | A |
6144444 | Haworth et al. | Nov 2000 | A |
6168877 | Pedicini et al. | Jan 2001 | B1 |
6365338 | Bull et al. | Apr 2002 | B1 |
6375611 | Voss et al. | Apr 2002 | B1 |
6375613 | Brasile | Apr 2002 | B1 |
6389308 | Shusterman | May 2002 | B1 |
6402461 | Tebby | Jun 2002 | B1 |
6475716 | Seki | Nov 2002 | B1 |
6490880 | Walsh | Dec 2002 | B1 |
6492103 | Taylor | Dec 2002 | B1 |
6492745 | Colley, III et al. | Dec 2002 | B1 |
6524785 | Cozzone et al. | Feb 2003 | B1 |
6569615 | Thatte et al. | May 2003 | B1 |
6582953 | Brasile | Jun 2003 | B2 |
6600941 | Khuri | Jul 2003 | B1 |
6609987 | Beardmore | Aug 2003 | B1 |
6631830 | Ma et al. | Oct 2003 | B2 |
6642045 | Brasile | Nov 2003 | B1 |
6673594 | Owen et al. | Jan 2004 | B1 |
6696238 | Murphy et al. | Feb 2004 | B2 |
6740484 | Khirabadi et al. | May 2004 | B1 |
6783328 | Lucke et al. | Aug 2004 | B2 |
6792309 | Noren | Sep 2004 | B1 |
6794124 | Steen | Sep 2004 | B2 |
6811965 | Vodovotz et al. | Nov 2004 | B2 |
6878339 | Akiyama et al. | Apr 2005 | B2 |
6894690 | Capers | May 2005 | B2 |
6906325 | Quek | Jun 2005 | B2 |
6925324 | Shusterman | Aug 2005 | B2 |
6953655 | Hassanein et al. | Oct 2005 | B1 |
6974436 | Aboul-Hosn et al. | Dec 2005 | B1 |
7001354 | Suzuki et al. | Feb 2006 | B2 |
7008380 | Rees et al. | Mar 2006 | B1 |
7238165 | Vincent et al. | Jul 2007 | B2 |
7316666 | Entenman et al. | Jan 2008 | B1 |
7452711 | Daykin | Nov 2008 | B2 |
7572622 | Hassanein et al. | Aug 2009 | B2 |
7651835 | Hassanein et al. | Jan 2010 | B2 |
8304181 | Hassanein et al. | Nov 2012 | B2 |
8323954 | Kravitz et al. | Dec 2012 | B2 |
8409846 | Hassanein et al. | Apr 2013 | B2 |
8420380 | Fishman et al. | Apr 2013 | B2 |
8465970 | Hassanein et al. | Jun 2013 | B2 |
8535934 | Hassanein et al. | Sep 2013 | B2 |
8585380 | Hassanein et al. | Nov 2013 | B2 |
8822203 | Hassanein et al. | Sep 2014 | B2 |
9215867 | Hassanein et al. | Dec 2015 | B2 |
9457179 | Hassanein et al. | Oct 2016 | B2 |
9462802 | Fishman et al. | Oct 2016 | B2 |
9894894 | Hassanein et al. | Feb 2018 | B2 |
10321676 | Hassanein et al. | Jun 2019 | B2 |
10736314 | Hassanein et al. | Aug 2020 | B2 |
10750738 | Fishman et al. | Aug 2020 | B2 |
20010003652 | Freeman | Jun 2001 | A1 |
20010025191 | Montgomery | Sep 2001 | A1 |
20020012988 | Brasile | Jan 2002 | A1 |
20020102720 | Steen | Aug 2002 | A1 |
20020132220 | Berens et al. | Sep 2002 | A1 |
20020151950 | Okuzumi | Oct 2002 | A1 |
20020164795 | Gen | Nov 2002 | A1 |
20020177117 | Wolf | Nov 2002 | A1 |
20020187132 | Mcgregor et al. | Dec 2002 | A1 |
20030040665 | Khuri et al. | Feb 2003 | A1 |
20030050689 | Matson | Mar 2003 | A1 |
20030053998 | Daemen et al. | Mar 2003 | A1 |
20030073227 | Hull et al. | Apr 2003 | A1 |
20030074760 | Keller | Apr 2003 | A1 |
20030086830 | Haywood et al. | May 2003 | A1 |
20030111604 | Quek | Jun 2003 | A1 |
20030135152 | Kollar et al. | Jul 2003 | A1 |
20030147466 | Liang | Aug 2003 | A1 |
20040015042 | Vincent et al. | Jan 2004 | A1 |
20040017658 | Lo et al. | Jan 2004 | A1 |
20040018966 | Segall et al. | Jan 2004 | A1 |
20040029096 | Steen | Feb 2004 | A1 |
20040038192 | Brasile | Feb 2004 | A1 |
20040058432 | Owen et al. | Mar 2004 | A1 |
20040082057 | Alford et al. | Apr 2004 | A1 |
20040086578 | Segall et al. | May 2004 | A1 |
20040102415 | Thatte et al. | May 2004 | A1 |
20040102678 | Haindl | May 2004 | A1 |
20040106958 | Mathis et al. | Jun 2004 | A1 |
20040110800 | Bril et al. | Jun 2004 | A1 |
20040115689 | Augello et al. | Jun 2004 | A1 |
20040138542 | Khuri et al. | Jul 2004 | A1 |
20040168341 | Petersen et al. | Sep 2004 | A1 |
20040170950 | Prien | Sep 2004 | A1 |
20040171138 | Hassanein et al. | Sep 2004 | A1 |
20040193096 | Cooper | Sep 2004 | A1 |
20040202993 | Poo et al. | Oct 2004 | A1 |
20040221719 | Wright et al. | Nov 2004 | A1 |
20040224298 | Brassil et al. | Nov 2004 | A1 |
20040235142 | Schein et al. | Nov 2004 | A1 |
20040236170 | Kim | Nov 2004 | A1 |
20040248281 | Wright et al. | Dec 2004 | A1 |
20050010118 | Toyoda et al. | Jan 2005 | A1 |
20050019917 | Toledo-Pereyra et al. | Jan 2005 | A1 |
20050142532 | Poo et al. | Jun 2005 | A1 |
20050147958 | Hassanein et al. | Jul 2005 | A1 |
20050153271 | Wenrich | Jul 2005 | A1 |
20050170019 | Roth | Aug 2005 | A1 |
20050182349 | Linde et al. | Aug 2005 | A1 |
20050187469 | Phillips | Aug 2005 | A1 |
20050253390 | Blazek | Nov 2005 | A1 |
20060039870 | Turner | Feb 2006 | A1 |
20060074470 | Bartels et al. | Apr 2006 | A1 |
20060121438 | Toledo-Pereyra et al. | Jun 2006 | A1 |
20060124130 | Bonassa | Jun 2006 | A1 |
20060134073 | Naka et al. | Jun 2006 | A1 |
20060148062 | Hassanein et al. | Jul 2006 | A1 |
20060154357 | Hassanein et al. | Jul 2006 | A1 |
20060154359 | Hassanein et al. | Jul 2006 | A1 |
20060160204 | Hassanein et al. | Jul 2006 | A1 |
20060292544 | Hassanein et al. | Dec 2006 | A1 |
20070196461 | Weers | Aug 2007 | A1 |
20070275364 | Hassanein et al. | Nov 2007 | A1 |
20080017191 | Davies et al. | Jan 2008 | A1 |
20080017194 | Hassanein et al. | Jan 2008 | A1 |
20080234768 | Hassanein et al. | Sep 2008 | A1 |
20080286746 | Poo et al. | Nov 2008 | A1 |
20090142830 | Yamashiro et al. | Jun 2009 | A1 |
20090143417 | Smith et al. | Jun 2009 | A1 |
20090197240 | Fishman et al. | Aug 2009 | A1 |
20090197241 | Fishman et al. | Aug 2009 | A1 |
20090197292 | Fishman et al. | Aug 2009 | A1 |
20090197324 | Fishman et al. | Aug 2009 | A1 |
20090197325 | Fishman et al. | Aug 2009 | A1 |
20090215022 | Page et al. | Aug 2009 | A1 |
20090312724 | Pipkin et al. | Dec 2009 | A1 |
20100056966 | Toth | Mar 2010 | A1 |
20100092939 | Belous et al. | Apr 2010 | A1 |
20100119554 | Dobson | May 2010 | A1 |
20110076666 | Brassil | Mar 2011 | A1 |
20110136096 | Hassanein et al. | Jun 2011 | A1 |
20110190572 | Brophy et al. | Aug 2011 | A1 |
20110212431 | Bunegin et al. | Sep 2011 | A1 |
20120277681 | Kravitz | Nov 2012 | A1 |
20130011823 | Hassanein et al. | Jan 2013 | A1 |
20130078710 | Hassanein et al. | Mar 2013 | A1 |
20130157248 | Fishman et al. | Jun 2013 | A1 |
20130295552 | Hassanein et al. | Nov 2013 | A1 |
20140017658 | Steinman et al. | Jan 2014 | A1 |
20140017660 | Steinman et al. | Jan 2014 | A1 |
20140135738 | Panian | May 2014 | A1 |
20150079580 | Hassanein et al. | Mar 2015 | A1 |
20150230453 | Fontes et al. | Aug 2015 | A1 |
20200337298 | Hassanein et al. | Oct 2020 | A1 |
20200352155 | Fishman et al. | Nov 2020 | A1 |
Number | Date | Country |
---|---|---|
2881613 | Nov 2007 | CA |
1232723 | Oct 1999 | CN |
1269471 | Oct 2000 | CN |
2418882 | Feb 2001 | CN |
1452863 | Nov 2003 | CN |
101072500 | Nov 2007 | CN |
101404968 | Apr 2009 | CN |
101977649 | Feb 2011 | CN |
4201259 | Jul 1993 | DE |
10121159 | Nov 2002 | DE |
0347923 | Dec 1989 | EP |
0376763 | Jul 1990 | EP |
1017271 | Jul 2000 | EP |
1942726 | Jul 2008 | EP |
3347084 | Nov 2020 | EP |
S57-010695 | Jan 1982 | JP |
63270601 | Nov 1988 | JP |
H02-282301 | Nov 1990 | JP |
02-306901 | Dec 1990 | JP |
H03-74302 | Mar 1991 | JP |
04-099701 | Mar 1992 | JP |
H04-128201 | Apr 1992 | JP |
06-056601 | Mar 1994 | JP |
06-305901 | Nov 1994 | JP |
H07-196401 | Aug 1995 | JP |
08-511012 | Nov 1996 | JP |
09-500380 | Jan 1997 | JP |
H09-500481 | Jan 1997 | JP |
2001061956 | Mar 2001 | JP |
2001516768 | Oct 2001 | JP |
2002-119586 | Apr 2002 | JP |
2003-206201 | Jul 2003 | JP |
2003-315220 | Nov 2003 | JP |
2004513889 | May 2004 | JP |
2004525290 | Aug 2004 | JP |
2004529938 | Sep 2004 | JP |
2008-515914 | May 2008 | JP |
2009-521931 | Jun 2009 | JP |
2010-525076 | Jul 2010 | JP |
2011-511000 | Apr 2011 | JP |
2016-53030 | Apr 2016 | JP |
6144238 | Jun 2017 | JP |
6625384 | Dec 2019 | JP |
2020-138976 | Sep 2020 | JP |
6756775 | Sep 2020 | JP |
6757829 | Sep 2020 | JP |
WO-8805261 | Jul 1988 | WO |
WO-9502326 | Jan 1995 | WO |
WO-9503680 | Feb 1995 | WO |
WO-9531897 | Nov 1995 | WO |
WO-9618293 | Jun 1996 | WO |
WO-9629865 | Oct 1996 | WO |
WO-9746091 | Dec 1997 | WO |
WO-9915011 | Apr 1999 | WO |
WO-0022927 | Apr 2000 | WO |
WO-0035340 | Jun 2000 | WO |
WO-0060936 | Oct 2000 | WO |
WO-0226034 | Apr 2002 | WO |
WO-0235929 | May 2002 | WO |
WO-02089571 | Nov 2002 | WO |
WO-2003026419 | Apr 2003 | WO |
WO-2004017838 | Mar 2004 | WO |
WO-2004026031 | Apr 2004 | WO |
WO-2006042138 | Apr 2006 | WO |
WO-2006060309 | Jun 2006 | WO |
WO-2006076590 | Jul 2006 | WO |
WO-2006124820 | Nov 2006 | WO |
WO-2007079185 | Jul 2007 | WO |
WO-2007124044 | Nov 2007 | WO |
WO-2008106724 | Sep 2008 | WO |
WO-2008150587 | Dec 2008 | WO |
WO-2009099939 | Aug 2009 | WO |
WO-2011072012 | Jun 2011 | WO |
WO-2012142487 | Oct 2012 | WO |
WO-2012148685 | Nov 2012 | WO |
WO-2013068752 | May 2013 | WO |
WO-2014011547 | Jan 2014 | WO |
WO-2014059316 | Apr 2014 | WO |
WO-2014194349 | Dec 2014 | WO |
WO-2015154170 | Oct 2015 | WO |
WO-2015154172 | Oct 2015 | WO |
Entry |
---|
Ida, K. “Titanium for Medical and Dental Use”, Japanese journal of medical electronics and biological engineering, 24(1):47-54, 1986 (12 pages)—with English Summary. |
“2002 Design & Engineering Awards, Portable Organ Preservation System”, Science (2002) (1 page). |
“Celsior™ Cold Storage Solution”, Sangstat Medical Corporation (internet reference) (1999) (5 pages). |
“History of Transplantation and Organ Preservation,” Barr Laboratories, Inc. (2004) (4 pages). |
“Human heart beats on its own outside body”, USA Today (2001) (1 page). |
“Human Heart Kept Alive Outside Body for First Time in Study of Portable Organ Preservation System™ at University of Pittsburgh Medical Center”, UPMC, McGowan Institute for Regenerative Medicine (2001) (2 pages). |
“Machine Keeps Human Kidney Alive for 24-Hours”, American Academy of Anti-Aging Medicine, 222.worldhealth.net, Aug. 25, 2001, (<http://wwwworldhealth.net/p/393,1313.htm>) By Richard Klatz , Accessed Jul. 5, 2006 (1 page). |
“Machine may be organ transplant breakthrough”, USA Today, by Stephen J. Carrera (<http://www.usatoday.com/news/health/2001-08-25-organ.htm>) (Aug. 5, 2001) (1 page). |
“New discovery in organ transplantation”, MSNBC Chicago, No Author Listed (2001) (www.nbc5/com <http://www.nbc5/com>) (1 page). |
“The Nation: Warm-Storage Device May Aid Organ Transplants”, Dow Jones Publications Library (2001) (1 page). |
“ViaSpan (Belzer UW) Cold Storage Solution”, Barr Laboratories, Inc. (2002), 2 pages. |
“Warm storage for donor organs”, University of Chicago Magazine (2001) (1 page). |
Ahmad, N. et al., “A pathophysiologic study of the kidney tubule to optimize organ preservation solutions”, Kidney International 66(1):77-90 (2004), 14 pages. |
Aitchison, et al., “Functional Assessment of Non-Heart-Beating Donor Lungs: Prediction of Post-Transplant Function”, European Journal of Cardio-thoracic Surgery, 20:187-194 (2001). |
Aitchison, J.D. et al., “Nitric Oxide During Perfusion Improves Posttransplantation Function of Non-Heart-Beating Donor Lungs”, Transplantation, 75(12):1960-1964, Jun. 27, 2003, 5 pages. |
Anathaswamy, A., “Machine keeps organs alive for longer”, NewScientist.com, Aug. 16, 2001, (<http://www.newscientist.com/article.ns?id=dn1168&print=true> (1 page). |
Aoki, M. et al., Anti-CD18 Attenuates Deleterious Effects of Cardiopulmonary Bypass and Hypothermic Circulatory Arrest in Piglets, J. Card. Surg. 10(Suppl):407-17 (1995) (11 pages). |
Bando, K. et al., “Oxygenated perfluorocarbon, recombinant human superoxide dismutase, and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation”, J. Thorac Cardiovasc Surg. 96:930-8 (Dec. 1988), 9 pages. |
Barinov, E.F., “Hormonal-metabolic disturbances during biological preservation of the heart”, Fiziologicheskii Zhurnal (Kiev), 29(3):293-299 (1983) (8 pages)—Russian Language with English Abstract. |
Belzer, F.O., “Formula for Belzer MPS Solution”, University of Wisconsin-Madison Organ Preservation, (<http://www.surgery.wisc.edu/transplat/research/southard/BelzerMPS.shtml>) (Oct. 3, 2003) (2 pages). |
Benichou, J. et al., “Canine and Human Liver Preservation for 6 to 18 HR by Cold Infusion”, Transplantation, 24(6):407-411 (Dec. 1977) (5 pages). |
Birkett, D. et al., “The Fatty Acid Content and Drug Binding Characteristics of Commercial Albumin Preparations”, Clinica Chimica Acta 85:253-258 (1978), 6 pages. |
Blanchard, J.M. et al., “Techniques for Perfusion and Storage of Heterotopic Heart Transplants in Mice”, Microsurgery, 6:169-174 (1985), 6 pages. |
Boggi, U. et al., “Pancreas Preservation with University of Wisconsin and Celsior Solutions”, Transplant Proceedings 36(3):563-565 (2004), 3 pages. |
Boggi, U. et al., “Pancreas Preservation With University of Wisconsin and Celsior Solutions: A Single-Center, Prospective, Randomized Pilot Study”, Transplantation 27:77(8):1186-1190 (2004), 5 pages. |
Botha, P., “Extended Donor Criteria in Lung Transplantation”, Current Opinion in Organ Transplantation, 14:206-210, 2009 (5 pages). |
Boyle, E.M. Jr. et al., “Ischemia-Reperfusion Injury”, Ann. Thorac. Surg. 64:S24-S30 (1997), 7 pages. |
Brandes, H. et al. “Influence of High Molecular Dextrans on Lung Function in an ex Vivo Porcine Lung Model,” Journal of Surgical Research, 101:2, 225-231 (2001) (7 pages). |
Brasile, L. et al., “Organ Preservation Without Extreme Hypothermia Using an Oxygent™ Supplemented Perfusate”, Art. Cells, Blood Subs., and Immob. Biotech., 22(4):1463-68 (1994), 6 pages. |
Burt, J.M. et al, “Myocardial function after preservation for 24 hours”, J. Thorac. Cardiovasc Surg., 92(2):238-46 (1986), 9 pages. |
Calhoon, J.H. et al., “Twelve-Hour Canine Heart Preservation With A Simple, Portable Hypothermic Organ Perfusion Device”, Ann. Thorac. Surg., 62:91-3 (1996), 3 pages. |
Canelo R. et al., “Experience with Hystidine Tryptophan Ketoglutarate Versus University Wisconsin Preservation Solutions in Transplantation”, Int. Surg. 88(3):145-51 (2003), 8 pages. |
Carrier, B., “Chapter 4: Hypoxia and Oxygenation”, Alaska Air Medical Escort Training Manual, Fourth Edition, pp. 71-82, 2006, 12 pages. |
Chambers, D.J. et al., “Long-Term Preservation of the Heart: The Effect of Infusion Pressure During Continuous Hypothermic Cardioplegia”, The Journal of Heart and Lung Transplantation, 11(4):665-75 (1992), 11 pages. |
Chen, F. et al., “Development of New Organ Preservation Solutions in Kyoto University”, Yonsei Medical Journal, 46(6):1107-40 (2004), 8 pages. |
Chien, S. et al., “A simple technique for multiorgan preservation”, The Journal of Thoracic and Cardiovascular Surgery, 95(1):55-61 (1988), 7 pages. |
Chien, S. et al., “Canine Lung Transplantation After More than Twenty-four Hours of Normothermic Preservation”, The Journal of Heart and Lung Transplantation, 16:340-51 (1997), 12 pages. |
Chien, S. et al., “Functional Studies of the Heart During a 24-Hour Preservation Using a New Autoperfusion Preparation”, The Journal of Heart and Lung Transplantation, 10(3):401-8 (1991), 8 pages. |
Chinchoy, Edward Cheng-wey; “The Development, Refinement, and Uses of a Physiologically Working Isolated Ex Vivo Swine Heart Model”, A thesis submitted to the Faculty of the Graduate School of athe University of Minnesota, Dec. 1999 (136 pages). |
Christophi, C. et al., “A Comparison of Standard and Rapid Infusion Methods of Liver Preservation During Multi-Organ Procurement”, Aust. N.Z.J. Surg., 61(9):692-694 (1991), 3 pages. |
Cimino, Adria, “Doctor develops device to preserve donated organs”, Mass High Tech (2001), 2 pages. |
CNN.com, “Heart kept beating outside body”, Associated Press CNN News Health Section (Oct. 7, 2001, 02:59) (CNN.com/Health with WebMD.com), 2 pages. |
Collins, B.H., “Organ Transplantation: What Is the State of the Art?”, Annals of Surgery, 238(6 Suppl):S72-S89 (2003), 18 pages. |
Cronin, D.C. et al., “Chapter 21: Liver Transplantation at The University of Chicago”, Clinical Transplants 231-238 (1999), 9 pages. |
Daemen, J.H.C. et al., “Short-term outcome of kidney transplants from non-heart-beating donors after preservation by machine perfusion”, Transpl. Int. 9(Supp 1):S76-S80 (1996), 5 pages. |
Definition of Examine, Merriam-Webster Dictionary on-line. www.merriam-webster.com/dictionary/examine, Printed Feb. 9, 2011, (1 page). |
Demertzis, S. et al., “University of Wisconsin Versus St. Thomas' Hospital Solution for Human Donor Heart Preservation”, Ann Thorac Surg 55:1131-7 (1993), 7 pages. |
Den Butter, G. et al., “Comparison of solutions for preservation of the rabbit liver as tested by isolated perfusion”, Transpl. Int. 8(6):466-471 (1995), 6 pages. |
Denham, B.S. et al., “Twenty-Four Hour Canine Renal Preservation By Pulsatile Perfusion, Hypothermic Storage, and Combinations of the Two Methods”, Transplantation Proceedings, 9(3):1553-1556 (1977), 4 pages. |
Dobrian, A. et al., “In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin”, Biochimica et Biophysica Acta (BBA) 1169:12-24 (1993), 13 pages. |
Drexler, H. et al., “Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology,” Circulation 89(4):1615-1623 (1994) (10 pages). |
Egan, T. M. et al., “Ex Vivo Evaluation of Human Lungs for Transplant Suitability”, Ann Thorac Surg, vol. 81, No. 4, pp. 1205-1213 (Apr. 2006) (9 pages). |
Eiseman, B. et al., “A disposable liver perfusion chamber”, Surgery 60(6):1183-1186 (1966), 4 pages. |
Engelman, R.M. et al., “Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass”, Ann Thorac Surg 60(3):801-04 (1995) (4 pages). |
European Search Report for European Patent Application No. 08795820.3 dated Apr. 17, 2014 (6 pages). |
European Search Report for European Patent Application No. 09707471.0 dated May 27, 2014 (7 pages). |
European Search Report issued in EP12770852.7, dated Sep. 23, 2014, 8 pages. |
Extended European Search Report issued in EP15803127.8, dated May 22, 2018 (14 pages). |
Extended European Search Report issued in European Application No. 17172411.5, dated Nov. 8, 2017 (7 pages). |
Fabregas, Luis, “UPMC tests machine to aid heart transplants”, Pittsburg Tribune-Review (Feb. 24, 2002), (<http://www.pittsburghlive.com/x/pittsburghrib/print_19181.html>), 2 pages. |
Faggian, G. et al., “Donor Organ Preservation in High-Risk Cardiac Transplantation”, Transplantation Proceedings 36:617-619 (2004), 3 pages. |
Featherstone, R.L. et al. “Comparison of Phosphodiesterase Inhibitors of Differing Isoenzyme Selectivity Added to St. Thomas' Hospital Cardioplegic Solution Used for Hypothermic Preservation of Rat Lungs”, Am J Respir Crit Care Med, Mar. 2000,162(3):850-856 (7 pages). |
Fehrenberg, C. et al., “Protective Effects of B2 Preservation Solution in Comparison to a Standard Solution (Histidine-Tryptophan-Ketoglutarate/Bretschneider) in a Model of Isolated Autologous Hemoperfused Porcine Kidney”, Nephron Physiol 96:52-58 (2004) (7 pages). |
Ferrera, R. et al., “Comparison of Different Techniques of Hypothermic Pig Heart Preservation”, Ann Thorac Surg 57(5):1233-1239 (1994), 7 pages. |
File History for U.S. Appl. No. 60/616,835, filed Oct. 7, 2004 (82 pages). |
File History for U.S. Appl. No. 60/694,971, filed Jun. 28, 2005 (280 pages). |
File History for U.S. Appl. No. 60/725,168, filed Oct. 6, 2005 (699 pages). |
Finn, A. et al., “Effects of Inhibition of Complement Activation Using Recombinant Soluble Complement Receptor 1 on Neutrophil CD11B/CD18 and L-Selectin Expression and Release of Interleukin-8 and Elastase in Simulated Cardiopulmonary Bypass”, J Thorac Cardiovasc Surg 111(2):451-459 (1996), 9 pages. |
Fourcade, C. et al., “Nouvelle Méthode De Conservation Du Rein Avec Une Solution De Collins”, <<A New Method of Kidney Preservation with Collins' Solution,>> Biomed. 21(7):308-11 (1974), English Abstract, 5 pages. |
Fraser, C.D. Jr. et al., “Evaluation of Current Organ Preservation Methods for Heart-Lung Transplantation”, Transplantation Proceedings, 20(1 Suppl. 1):987-990 (1988), 4 pages. |
Glucose, The Merck Index, 11th ed. Entry 4353 (pp. 699-700) (1989), 3 pages. |
Grynberg, A. et al., “Fatty Acid Oxidation in the Heart”, Journal of Cardiovascular Pharmacology, 28(Suppl. 1):S11-S17 (1996) (8 pages). |
Guarrera, J.V. et al., “Pulsatile Machine Perfusion With Vasosol Solution Improves Early Graft Function After Cadaveric Renal Transplantation”, Transplantation 77(8):1264-1268 (2004), 5 pages. |
Gundry, S.R. et al., “Successful Transplantation of Hearts Harvested 30 Minutes After Death From Exsanguination”, Ann Thorac Surg 53(5):772-775 (1992), 4 pages. |
Habazetti, H. et al., “Improvement in Functional Recovery of the Isolated Guinea IG Heart After Hyperkalemic Reperfusion With Adenosine”, J Thorac Cardiovasc Surg 111(1):74-84 (1996) (11 pages). |
Hachida, M. et al., Abstract “Efficacy of myocardial preservation using HTK solution in continuous 120 min cross-clamping method—a comparative study with GIK method”, Nippon Kyobu Geka Gakkai Zasshi. 41(9):1495-1501 (1993), 1 page. |
Hardesty, R.L. et al., Original Communications, “Autoperfusion of the heart and lungs for preservation during distant procurement”, J Thorac Cardiovasc Surg, 93:11-18 (1987) (8 pages). |
Hartman, J.C., “The Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of ACE Inhibitors”, Ann Thorac Surg 60:789-792 (1995), 4 pages. |
Hassanein, W.H. et al., “A Novel Approach for 12 Hour Donor Heart Preservation, Presented at the 70th Scientific Sessions of The American Heart Association”, Abstract was published in Circulation (1997), 1 page. |
Hassanein, W.H. et al., “Continuous Perfusion of Donor Hearts in the Beating State Extends Preservation Time and Improves Recovery of Function”, The Journal of Thoracic and Cardiovascular Surgery, pp. 821-830 (1998), 10 pages. |
Heil, J.E. et al., “A Controlled Comparison of Kidney Preservation by Two Methods: Machine Perfusion and Cold Storage”, Transplantation Proceedings 19(1):2046 (1987), 1 page. |
Howarth, F.C. et al., “Effects of extracellular magnesium and beta adrenergic stimulation on contractile force and magnesium mobilization in the isolated rat heart”, Magnesium Research, 7:187-197, 1994 (13 pages). |
Hülsmann, W.C et al., “Loss of cardiac contractility and severe morphologic changes by acutely lowering the pH of the perfusion medium: protection by fatty acids”, Bragen 20256, Biochimica et Biophysica Acta., 1033:214-218 (1990) (5 pages). |
Imber, C. et al., “Advantages of Normothermic Perfusion Over Cold Storage in Liver Preservation”, Transplantation, 73(5):701-709 (2002), 9 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2012/033626 dated Sep. 20, 2012 (12 pages). |
International Search Report and Written Opinion issued by the U.S. Patent and Trademark Office as Searching Authority, in International Application No. PCT/US16/50512, dated Dec. 12, 2016 (9 pages). |
International Search Report, issued by the European Patent Office as Searching Authority, in PCT/US07/009652 International Search Report, dated Apr. 18, 2008, 5 pages. |
International Search Report, issued by the European Patent Office as Searching Authority, issued in PCT/US98/19912, dated May 3, 1999 (4 pages). |
International Search Report, issued by the U.S. Patent Office as Searching Authority, issued in PCT/US08/61454 International search report dated Dec. 5, 2008 (2 pages). |
International Search Report, issued by the U.S. Patent Office as Searching Authority, issued in PCT/US09/032619, dated Jun. 4, 2009 (4 pages). |
Janßen, H. et al., “UW is Superior to Celsior and HTK in the Protection of Human Liver Endothelial Cells Against Preservation Injury”, Liver Transplantation, 10(12):1514-1523 (2004), 10 pages. |
Johnson, Kerry et al, “POPS: Portable Organ Preservation System”, UPMC Health System and TransMedics, Inc. (No date) (1 page). |
Johnston, R., “What's Normal About DLCO?”, PFT Blog, Jan. 1, 2014 (17 pages). |
Kawakami, et al., “Successful Preservation of the Isolated Canine Heart for 24 Hours by Low Pressure—Low Temperature Continuous Perfusion”, Japanese Annals of Thoracic Surgery, Japan, 7(6):543-547, Dec. 25, 1987 (13 pages)—English Translation. |
Kawamura, T. et al., “Long-Term Preservation of Canine Pancreas by a New Simple Cold Storage Method Using Perfluorochemical—The Two-Layer Cold Storage Method (Euro-Collins' Solution/Perfluorochemical)-”, Kobe J. Med. Sci., 38(2):135-145 (1992), 11 pages. |
Kelly, R.F., “Current strategies in lung preservation”, J. Lab Clin Med, 136:427-440 (2000), 14 pages. |
Keshavjee, S.H. et al., “A method for safe twelve-hour pulmonary preservation”, J Thorac Cardiovasc Surg, 98:529-534 (1989), 6 pages. |
Kioka, Y. et al., “Twenty-Four-Hour Isolated Heart Preservation by Perfusion Method With Oxygenated Solution Containing Perfluorochemicals and Albumin”, The Journal of Heart Transplantation, 5:437-443 (1986), 7 pages. |
Koike, et al., “An Experimental Study on the Hypothermic Preservation of the Rabbit Heart Using Glucose-Insulin-Potassium Solution—Intermittent Perfusion Method Versus Simple Immersion Method”, Japanese Annals of Thoracic Surgery, 7(6):527-532, Dec. 25, 1987 (16 pages)—English Translation. |
Kozaki, K. et al., “Usefulness of a Combination of Machine Perfusion and Pentoxifylline for Porcine Liver Transplantation From Non-Heart-Beating Donors With Prolonged Hypotension”, Transplantation Proceedings, 29:3476-3477 (1997), 2 pages. |
Kubono, K. et al., “Examination of Plasma and Corpuscle Adenosine Concentration in Normal Subject by Radioimmunoassay”, Rinshou Kagaku (Clinical Chemistry, 20(2):72-77, Jun. 1991 (6 pages)—Japanese Language. |
Kuroda, Y. et al., “A New, Simple Method for Cold Storage of the Pancreas Using Perfluorochemical”, Transplantation, 46(3):457-460 (1988), 4 pages. |
Lasley, R.D. et al., “Protective Effects of Adenosine in the Reversibly Injured Heart”, Ann Thorac Surg, 60(3):843-846 (1995), 4 pages. |
Lawrence, C., “Machine preserves organs outside body,” Chicago Sun Times (2001), 1 page. |
Lefer, A.M., “Attenuation of Myocardial Ischemia-Reperfusion Injury With Nitric Oxide Replacement Therapy”, Ann Thorac Surg 60(3):847-851 (1995), 5 pages. |
Li, G. et al., “Functional Recovery in Rabbit Heart after Preservation with a Blood Cardioplegic Solution and Perfusion,” J Heart Lung Transplant, 12(2)263-270 (1993) (8 pages). |
Li, X. et al., “Insulin in University of Wisconsin Solution Exacerbates the Ischemic Injury and Decreases the Graft Survival Rate in Rat Liver Transplantation”, Transplantation, 15:76(1):44-49 (2003), 6 pages. |
Li, X. et al., “Insulin in UW Solution Exacerbates Hepatic Ischemia / Reperfusion Injury by Energy Depletion Through the IRS-2 / SREBP—1c Pathway”, Liver Transplantation, 10(9):1173-1182 (2004), 10 pages. |
Liu,J. et al., “Annexin V Assay-proven Anti-apopototic Effect of Ascorbic Acid 2-glucoside after Cold Ischemia/Reperfusion Injury in Rat Liver Transplantation”, Acta Med. Okayama, 57(5):209-216 (2003), 8 pages. |
Macchiarini, P. et al. “Ex Vivo Lung Model of Pig-to-Human Hyperacute Xenograft Rejection”, The Journal of Thoracic and Cardiovascular Surgery, 114:3, 315-325 (2000) (11 pages). |
Mankad, P. et al., “Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart”, J Thorac Cardiovasc Surg 104(6): 1618-1624 (1992), 7 pages. |
Matsuno, N. et al., “Effectiveness of Machine Perfusion Preservation as a Viability Determination Method for Kidneys Procured from Non-Heart-Beating Donors,” Transplantation Proceedings, 26(4):2421-2422 (1994) (2 pages). |
Matsuno, N. et al., “The Effect of Machine Perfusion Preservation Versus Cold Storage on the Function of Kidneys From Non-Heart-Beating Donors”, Transplantation, 57(2):293-294 (1994) (2 pages). |
Menasché, P. et al., “Experimental evaluation of Celsior®, a new heart preservation solution,” Eur J Cardio-thorac Surg 8:207-213 (1994), 7 pages. |
Menasché, P. et al., “Improved recovery of heart transplants with a specific kit of preservation solutions,” The Journal of Thoracic and Cardiovascular Surgery, 105(2):353-363 (1993), 11 pages. |
Menasché, P., “The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function”, Current Opinion in Cardiology, 10:597-604 (1995) (8 pages). |
Moisiuk, Y. et al., “Histidine-Tryptophan-Ketoglutarate Versus Euro-Collins for Preservation of Kidneys From Non-Heart-Beating Donors”, Transplantation Proceedings, 28(1):202 (1996) (1 page). |
Moller-Pedersen, T. et al., “Evaluation of potential organ culture media for eye banking using human donor corneas”, Br J Ophthamol, 85(9):1075-1079 (2001), 5 pages. |
Morimoto, T. et al., “A Simple Method for Extended Heart-Lung Preservation by Autoperfusion”, Trans Am Soc Artif Intern Organs, 30:320-324 (1984), 5 pages. |
Nicholson, M.L. et al., “A Comparison of Renal Preservation by Cold Storage and Machine Perfusion Using a Porcine Autotransplant Model”, Transplantation 78(3):333-337 (2004), 5 pages. |
No Author Listed, “Custodiol® HTK Solution for Multi-Organ Protection”, Saudi Center for Organ Transplantation, Date Unknown, originally cited to U.S. Patent Office Jun. 30, 2014, in U.S. Appl. No. 12/892,451 (2 pages). |
No Author Listed, “SOLTRAN Kidney perfusion fluid”, Baxter, No Month Listed—2001-2004 (1 page). |
No Author Listed, “The comprehensive resource for physicians, drug and illness information”, VIASPAN™ DuPont Pharma Cold Storage Solution, Date Unknown (3 pages). |
No Author Listed, “UW Solution Composition”, DuPont Pharmaceutical, Date Unknown (1 page). |
No Author Listed. “Custodiol HTK” Physicians' Desk Reference, 57th Edition, Thomson PDR. ISBN:1-56363-445-457. No Month Listed—2003 (3 pages). |
Odagiri, S. et al., “Pusatile Assist Device: New Pulsatile Pump Using Pulsatile Assist Device-Hemodynamic Comparison of Pulsatile V-A Bypass (VABP), Pulsatile Left Heart Bypass (LHBP) and Constant Flow Left Heart Bypass (LHB)”, Journal of Japan Surgical Society, 83(6):515-523, Jun. 1982, 12 pages—English Abstract. |
Opelz, G. et al., “Advantage of Cold Storage Over Machine Perfusion for Preservation of Cadaver Kidneys”, Transplantation, 33(1):64-68 (1982), 5 pages. |
Opelz, G. et al., “Comparative Analysis of Kidney Preservation Methods”, Transplantation Proceedings 28(1):87-90 (1996), 4 pages. |
Ota, K. et al., “Artificial Organ”, Current State and Future of Substitution of Functions, pp. 150-151, 1983 (7 pages)—English Translation. |
Pearl, J.M. et al., Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution, Cardiovascular Surgery 107(1):257-264 (1994) (8 pages). |
Petrovsky, B.V. et al., “Justification and Application of a New Method for Transorganic Oxygen Preservation of the Kidneys”, Vestn. Akad. Med. Nauk, SSSR., (2):69-82 (1989)—English Abstract, 15 pages. |
Pinsky, D. et al., “Restoration of the cAMP Second Messenger Pathway Enhances Cardiac Preservation for Transplantation in a Heterotopic Rat Model”, J. Clin. Invest. 92(6):2944-3002 (1993) (9 pages). |
Ploeg, R.J. et al., “Successful 72-Hour Cold Storage of Dog Kidneys With UW Solution”, Transplantation, 46(2):191-196 (1988), 6 pages. |
Pokorny, H. et al., “Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation—a prospective multi-centre observation study”, Transpl Int 17(5):256-260 (2004), (5 pages). |
Poston, R.S. et al., “Optimizing Donor Heart Outcome After Prolonged Storage With Endothelial Function Analysis and Continuous Perfusion”, Ann Thorac Surg, 78:1362-1370, 2004 (9 pages). |
Potdar, S. et al., “Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation”, Clin Transplant, 18(6):661-665 (2004), 5 pages. |
Pozniak, A., “Keeping Hearts Alive Doctors Develop a High-Tech System to Salvage Donated Organs”, ABC News.com, (Dec. 7, 2001) (<http://abcnews.go.com/print?id=117085>), (2 pages). |
Probst, R. et al. “Carbohydrate and fatty acid metabolism of cultured adult cardiac myocytes”, Am. J. Physiol. 250 (Heart, Circ. Physiol. 19):H853-H860 (1986) (8 pages). |
Pruitt, “Pharmacological Treatment of Respiratory Disorders”, RT Magazine, http://www.rtmagazine.com/2007/05/pharmacological-treatment-of-respiratory-disorders, May 3, 2007, accessed Jan. 1, 2019 (6 pages). |
Rao, V. et al., “Donor Blood Perfusion Improves Myocardial Recovery After Heart Transplantation”, J. Heart Lung Transplant. 16(6):667-673 (1997) (7 pages). |
Reddy, S.P. et al., “Preservation of Porcine Non-Heart-Beating Donor Livers by Sequential Cold Storage and Warm Perfusion”, Transplantation, 77(9):1328-1332 (2004), 5 pages. |
Richens, D. et al., “Clinical Study of Crystalloid Cardiplegia vs Aspartate-Enriched Cardioplegia Plus Warm Reperfusion for Donor Heart Preservation”, Transplantation Proceedings 24(1): 1608-1610 (1993) (3 pages). |
Rinder, C.S. et al., “Blockade of C5a and C5b-9 Generation Inhibits Leukocyte and Platelet Activation during Extracorporeal Circulation”, J. Clin. Invest. 96:3(1564-1572) 1995 (9 pages). |
Rosenkranz, E.R., “Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation”, Ann Thorac Surg 60:797-800 (1995) (4 pages). |
Rossi, L. et al., “Innovations-report: New organ preservation solution easier to use”, (<http://www.innovations-report.com/html/reports/medicine_report-18854.html>), Feb. 6, 2003 (2 pages). |
Rossi, L., “Portable Organ Preservation System™ Keeps Human Heart Alive Outside Body”, PITT Campaign Chronicle (Oct. 7, 2001), 2 pages. |
Schmid, T. et al., “The Use of Myocytes as a Model for Developing Successful Heart Preservation Solutions”, Transplantation 52(1):20-26 (Jul. 1991) (7 pages). |
Schon, M.R. et al., “Liver Transplantation After Organ Preservation With Normothermic Extracorporeal Perfusion”, Annals of Surgery 233(1):114-123 (2001), 10 pages. |
Schwalb, H. et al., “New Solution for Prolonged Myocardial Preservation for Transplantation”, The Journal of Heart and Lung Transplantation 17(2):222-229 (1998), 8 pages. |
Seccombe, J.F. et al., “Coronary Artery Endothelial Function After Myocardial Ischemia and Reperfusion”, Ann Thorac Surg 60(3):778-788 (1995), 11 pages. |
Segel, L.D. et al., “Posttransplantation Function of Hearts Preserved with Fluorochemical Emulsion”, J Heart Lung Transplant, 13(4):669-680 (1994), 12 pages. |
Segel,L.D. et al., “Recovery of Sheep Hearts After Perfusin Preservation or Static Storage with Crystalloid Media”, The Journal of Heart and Lung Transplantation, 17:211-221 (1998) (11 pages). |
Sekine, M. et al., “Effect of Obese and Aging on Blood Fatty Acid Consumption in Japanese”, Bulletin of the Graduate School of Human Life Science, Showa Women's University, 4:63-70, 1995 (8 pages)—English Abstract. |
Semat, H. and Katz, R., “Physics, Chapter 9: Hydrodynamics (Fluids in Motion)”, Hydrodynamics. University of Nebraska—Lincoln. Pap143. No Month Listed 1958 (18 pages). |
Shimokawa, S. et al., “A New Lung Preservation Method of Topical Cooling by Ambient Cold Air Combined with High-Frequency Oscillation: An Experiemental Study”, Transplantation Proceedings, 26(4):2364-2366 (1994) (3 pages). |
Shimokawa, S. et al., “A New Lung Preservation Method of Topical Cooling by Ambient Cold Air: An Experimental Study”, Transplantation Proceedings, 23 (1):653-654 (1991) (2 pages). |
Shirakura, R. et al., “Multiorgan Procurement from Non-Heart-Beating Donors by use of Osaka University Cocktail, Osaka Rinse Solution, and the Portable Cardiopulmonary Bypass Machine”, Transplantation Proceedings, 25(6):3093-3094 (1993) (2 pages). |
Southard, J., “The Right Solution for Organ Preservation”, Business Briefings: Global Surgery 79-84 (2004) (6 pages). |
Steen, S. et al., “Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo”, Ann Thorac Surg, 76:244-252, 2003, 11 pages. |
Stubenitsky, B.M. et al., “Kidney preservation in the next millenium”, Transpl Int, 12:83-91 (1999), 9 pages. |
Sunamori, M. et al., “Relative Advantages of Nondepolarizing Solution to Depolarizing University of Wisconsin Solution in Donor Heart Preservation”, Transplantation Proceedings, 25(1): 1613-1617 (1993), 5 pages. |
Synchrony Definition, http://dictionary.reference.com/browse/synchrony, Random House Unabridged Dictionary, 2006 (1 page). |
Tang, D.G. et al., “Warm Ischemia Lung Protection With Pinacidil: An ATP Regulated Potassium Channel Opener”, Ann Thorac Surg, 76:385-390 (2003), 6 pages. |
Tesi, R.J. et al., Pulsatile Kidney Perfusion for Preservation and Evaluation: Use of High-Risk Kidney Donors to Expand the Donor Pool, Transplantation Proceedings, 25(6):3099-3100 (1993) (2 pages). |
Turpin, B.P. et al., “Perfusion of Isolated Rat Adipose Cells”, The Journal of Clinical Investigation, 60:442-448 (1977), 7 pages. |
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, “Drugs@FDA—Solu-Medrol: Label and Approval History”, (Available online at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist . . .), accessed Feb. 9, 2010 (3 pages). |
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, “Drugs@FDA—Solu-Medrol: Drug Details”, (Accessible online at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails . . .), accessed Feb. 9, 2010 (1 page). |
Vinten-Johansen, J. et al., “Reduction in Surgical Ischemic-Reperfusion Injury With Adenosine and Nitric Oxide Therapy”, Ann Thorac Surg 60(3):852-857 (1995), 6 pages. |
Voiglio, E. et al. “Rat Multiple Organ Blocks: Microsurgical Technique of Removal for Ex Vivo Aerobic Organ Preservation Using a Fluorocarbon Emulsion”, Microsurgery 20:3, 109-115 (2000) (7 pages). |
Watanabe, S. et al., “Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones”, Biochimica et Biophysica Acta (BGBA), 1289:385-396 (1996), 12 pages. |
Wei, Z., et al., “A Study on the Preservation of Rat Kidney with HX-III Solution”, J WCUMS, 31(3):347-349 (2000)—English Abstract, 4 pages. |
Wicomb, W. et al., “Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution”, J. Thorac Cardiovasc Surg, 83(1):133-140 (1982), 8 pages. |
Wicomb, W.N. et al., “24-Hour Rabbit Heart Storage With UW Solution”, Transplantation, 48(1):6-9 (1989), 4 pages. |
Wicomb, W.N. et al., “Cardiac Transplantation Following Storage of the Donor Heart by a Portable Hypothermic Perfusion System”, The Annals of Thoracic Surgery, 37(3):243-248 (1984), 6 pages. |
Wright, N. et al. “A porcine ex vivo paracorporeal model of lung transplantation”, Laboratory Animals Ltd. Laboratory Animals, 34:1, 56-62 (2000) (7 pages). |
Yang, et al., “Effect of Hypoxia and Reoxygenation on the Formation and Release of Reactive Oxygen Species by Porcine Pulmonary Artery Endothelial Cells”, Journal of Cellular Physiology, 164:414-423 (1995) (10 pages). |
Yeung, J., et al., “Physiologic assessment of the ex vivo donor lung for transplantation”, Journal of Heart and Lung Transplantation, 31(10):1120-1126, Oct. 2012 (7 pages). |
Yland, M.J. et al., “New Pulsatile Perfusion Method for Non-Heart-Beating Cadaveric Donor Organs: A Preliminary Report”, Transplantation Proceedings, 25(6):3087-3090 (1993), 4 pages. |
Yokoyama, H. et al., “Isolated Dog Hearts Prepared in Cold Tyrode Solution and Reperfused with Arterial Blood Are Functionally and Ultrastructurally Normal”, The Tohoku Journal of Experimental Medicine, 156:121-134, 1988 (14 pages). |
Zhang, Z. et al., “Research Progress on Preservation of Severed Limbs”, Chinese Journal of Reparative and Reconstructive Surgery, 14(3):189-192 (2000)—English Abstract, 8 pages. |
Chen, E. P. et al., “Milrinone Improves Pulmonary Hemodynamics and Right Ventricular Function in Chronic Pulmonary Hypertension”, Ann Thorac Surg, 63:814-821, 1997 (8 pages). |
Duarte, J.D. et al., “Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics”, Future Cardiol., 9(3):335-349, 2013 (15 pages). |
Givertz, M.M. et al., “Effect of Bolus Milrinone on Hemodynamic Variables and Pulmonary Vascular Resistance in Patients With Severe Left Ventricular Dysfunction: A Rapid Test for Reversibility of Pulmonary Hypertension”, JACC, 28(7):1775-1780, Dec. 1996 (6 pages). |
Han, B. et al., “Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease”, Experimental and Therapeutic Medicine, 16:1175-1186, 2018 (12 pages). |
Hoeper, M.M. et al., “Intensive Care Unit Management of Patients with Severe Pulmonary Hypertension and Right Heart Failure”, Am J Respir Crit Care Med, 184:1114-1124, 2011 (11 pages). |
Hui-Li, G. “The Management of Acute Pulmonary Arterial Hypertension”, Cardiovascular Therapeutics, 29:153-175, 2011 (23 pages). |
Jaski, B.E. et al., “Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside”, J. Clin Invest., 75(2):643-649, 1985 (8 pages). |
Lobato, E.B. et al., “Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension”, British Journal of Anaesthesia, 96(3):317-322, 2006 (6 pages). |
Open Anesthesia—Milrinone: pharmacology, https://www.openanesthesia.org/milrinone_pharmacology/, accessed 2019 (3 pages). |
Siobal, M.S. “Pulmonary Vasodilators”, Respir Care, 52(7):885-899, Jul. 2007 (15 pages). |
Russell, H.E. et al., “An Evaluation of Infusion Therapy (Including Dextran) for Venous Thrombosis”, Circulation, 33:839-846, Jun. 1966 (8 pages). |
Baker, L.E. et al., “Artificial Maintenance Media for Cell and Organ Cultivation”, Journal of Experimental Medicine, 70:29-38, Jul. 1, 1939 (15 pages). |
Rao, M.V. et al., “Magnesium Sulfate: Chemical and Technical Assessment”, MgSO4 (CTA), 2007 (5 pages). |
European Extended Search Report issued in EP 16844964.3, dated Apr. 26, 2019 (7 pages). |
Saez, D.G. et al., “Evaluation of the Organ Care System in Heart Transplantation With an Adverse Donor/Recipient Profile”, Ann. Thorac. Surg., 98:2099-2106, 2014 (8 pages). |
Sato, H. et al., “Supplemental L-Arginine During Cardioplegic Arrest and Reperfusion Avoids Regional Postischemic Injury”, J Thorac Cardiovasc Surg 110(2):302-314 (1995), (13 pages). |
European Search Report issued for European Application No. EP19204566.4, dated May 25, 2020 (7 pages). |
Gever, J., “Technique to Repair Damaged Donor Lungs for Graft Passes Clinical Test”, MedPage Today, https://www.medpagetoday.org/surgery/transplantation/12245, Accessed Jul. 11, 2020, dated Dec. 19, 2008 (4 pages). |
Gohrbandt, B., et al., “Glycine intravenous donor preconditioning is superior to glycine supplementation to low-potassium dextran flush preservation and improves graft function in a large animal lung transplantation model after 24 hours of cold ischemia”, The Journal of Thoracic and Cardiovascular Surgery, 131(3):724-729, Mar. 2006 (6 pages). |
Hai, Human Body Atlas, First Edition, Liaoning Science and Technology Publishing House, p. 120, Oct. 31, 2011 (3 pages)—with English Translation. |
Keshavjee, S.H. et al., “The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation”, Journal of Thoracic and Cardiovascular Surgery, 103(2):314-325, Feb. 1992 (12 pages). |
Wei, Y. et al., “Protective Effect of Specific Phosphodiesterase Inhibitor Milrinone for Donor Lungs”, Chinese Journal of New Drugs, 16(21):1762-1765, 2007—English Translation issued by U.S. Patent and Trademark Office, Aug. 2020 (17 pages). |
Jirsch, D.W. et al., “Ex Vivo Evaluation of Stored Lungs”, The Annals of Thoracic Surgery, 10(2):163-168, Aug. 1970 (6 pages). |
Venuta, F. et al., “History of lung transplantation”, Journal of Thoracic Disease, 9(12):5458-5471, Dec. 2017 (14 pages). |
Number | Date | Country | |
---|---|---|---|
20190110466 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
62215825 | Sep 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15258194 | Sep 2016 | US |
Child | 16230580 | US |